The Physalis Child : Identification of Cognitive and Emotional Factors
Identification of Cognitive and Emotional Factors in Relation to Auditory Hallucinations in Non-psychotic Children
1 other identifier
interventional
40
1 country
1
Brief Summary
The aim of this study is to show presence of cognitive and emotional factors on the beginning and persistence of auditory hallucinations in non-psychotic children. Investigators will describe a significant link between this factors and hallucinations in a sample of non-psychotic children. The results of this sample will be comparing to another group of children of the same age, sex and diagnosis, but without hallucination. Finally, investigators will control the persistence of hallucination on the first group after a six month period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2015
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 7, 2015
CompletedFirst Submitted
Initial submission to the registry
July 24, 2015
CompletedFirst Posted
Study publicly available on registry
October 5, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 7, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 7, 2017
CompletedJuly 30, 2018
July 1, 2018
2 years
July 24, 2015
July 27, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evolution of the score of theory of mind
The social cognitive marker will be evaluate by NeuroPsychologic assessment NEPSY II for theory of mind
Change from baseline 6 month later
Secondary Outcomes (8)
Evolution of the score of auditory hallucinations persistence
Change from baseline 6 month later
Evolution of the score of Mental Disorder
Change from baseline 6 month later
Evaluation of the score of Psychosis
Change from baseline 6 month later
Evolution of the score of individual stability
Change from baseline 6 month later
Evolution of measure of recognition of the feelings
Change from baseline 6 month later
- +3 more secondary outcomes
Study Arms (2)
Patients with auditory hallucination
EXPERIMENTALPatients with auditory hallucination: Evaluation at time 0 and 6 month after of: * The social cognitive marker (NeuroPsychologic assessment (NEPSY) II) : theory of mind and affect recognition * The emotional marker: * Differential Emotion Scale IV (DES IV): emotional individual stability * Revised Beliefs About Voices Questionnaire (BAVQ-R): a self report measure of patients' beliefs, emotional and behavior about auditory hallucination. * Evaluation of auditory hallucinations persistence with a self report scale using in recruiting criteria. * Evaluation of diagnosis with Diagnostic and Statistical Manual of Mental Disorders (DSM) -IV criteria: * Mini International Neuropsychiatric Interview (MINI) -Kids * "Psychosis" section of Kiddie-SADS
Patients without auditory hallucination
PLACEBO COMPARATORPatients without auditory hallucination: Evaluation at time 0 and 6 month after of: * The social cognitive marker (NEPSY II) : theory of mind and affect recognition * The emotional marker: * Differential emotion scale IV (DES IV): emotional individual stability * Revised Beliefs About Voices Questionnaire (BAVQ-R): a self report measure of patients' beliefs, emotional and behavior about auditory hallucination. * Evaluation of auditory hallucinations persistence with a self report scale using in recruiting criteria. * Evaluation of diagnosis with Diagnostic and Statistical Manual of Mental Disorders (DSM) -IV criteria: * Mini International Neuropsychiatric Interview (MINI) -Kids * "Psychosis" section of Kiddie-SADS (Schedule for Affective Disorders and Schizophrenia )
Interventions
Patients with auditory hallucination (20 for each arm): Evaluation at time 0 and 6 month after of: * The social cognitive marker (NEPSY II) : theory of mind and affect recognition * The emotional marker: * Differential emotion scale IV (DES IV): emotional individual stability * Revised Beliefs About Voices Questionnaire (BAVQ-R): a self report measure of patients' beliefs, emotional and behavior about auditory hallucination. * Evaluation of auditory hallucinations persistence with a self report scale using in recruiting criteria. * Evaluation of diagnosis with DSM-IV criteria: * MINI-Kids * "Psychosis" section of Kiddie-SADS
Patients without auditory hallucination (20 for each arm): Evaluation at time 0 and 6 month after of: * The social cognitive marker (NEPSY II) : theory of mind and affect recognition * The emotional marker: * Differential emotion scale IV (DES IV): emotional individual stability * Revised Beliefs About Voices Questionnaire (BAVQ-R): a self report measure of patients' beliefs, emotional and behavior about auditory hallucination. * Evaluation of auditory hallucinations persistence with a self report scale using in recruiting criteria. * Evaluation of diagnosis with DSM-IV criteria: * MINI-Kids * "Psychosis" section of Kiddie-SADS
Eligibility Criteria
You may qualify if:
- Twenty participants included with auditory hallucination:
- Boy or girl
- French
- Over six years old and under eighteen years old
- DSM-IV diagnosis of mood disorder, anxiety, disruptive behavioral disorder, attention deficit hyperactivity disorder, without schizophrenia diagnosis, without mental retardation (Intelligence Quotient (IQ)\>70),
- Parental and child consent, affiliated to social security.
- Twenty participants included without auditory hallucination:
- Boy or girl
- French,
- Over six years old and under eighteen years old
- DSM-IV diagnosis of mood disorder, anxiety, disruptive behavioral disorder, attention deficit hyperactivity disorder, without schizophrenia diagnosis, without mental retardation (IQ\>70)
- Parental and child consent, affiliated to social security.
You may not qualify if:
- schizophrenia diagnosis,
- neurologic, genetic or neurosensory disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fondation Lenvallead
Study Sites (1)
Fondation Lenval
Nice, 06200, France
Related Publications (1)
Dumas LE, Bonnard-Couton V, Golse B, Askenazy F. [Identifying cognitive and emotional markers in relation to auditory-verbal hallucinations in pediatric population: Physalis study]. Encephale. 2022 Oct;48(5):546-554. doi: 10.1016/j.encep.2021.06.010. Epub 2021 Oct 5. French.
PMID: 34625214DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Valérie BONNARD-COUTON, MD
Fondation Lenval
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 24, 2015
First Posted
October 5, 2015
Study Start
July 7, 2015
Primary Completion
July 7, 2017
Study Completion
July 7, 2017
Last Updated
July 30, 2018
Record last verified: 2018-07